Learn More About Sarcomatoid Carcinoma

What is Sarcomatoid cancer?SARC is an aggressive form of cancer and the
Sarcomatoid cancer (SARC) of the lung is a rareresultant tumors are frequently symptomatic, locally
type of Non-Small Cell Lung Cancer (NSCLC).advanced and have high rates of recurrence.
Non-Small Cell lung cancer accounts for about 80% ofNon-surgical treatments are usually recommended for
all lung cancers. There are several types of Non-Smallpatients with clinically advanced Sarcomatoid cancer.
Cell lung cancer and each type is associated with aInflammatory Sarcomatoid Carcinoma is an
uniquely different type of cancer cells. Sarcomatoidaggressive tumor with an unusually benign
cancer cells tend to invade the lung tissue moreappearance. Inflammatory SARC amounts to just
deeply than other types of cancerous cells.0.1% to 0.4% of all lung malignancies and most often
It has been suggested that radiotherapy for theoccurs in male smokers who are usually around 60
treatment of a patient's other cancer's may induce ayears of age at the time of diagnosis.
Sarcomatoid change in lung tissue which couldPatients most often present with cough, hemoptysis
preempt the subsequent development of a(coughing blood), chest pain, and dyspnea (shortness
Sarcomatoid Carcinoma.of breath). As with other non-small cell carcinomas of
Sarcomatoid cancer (SARC) is sometimes found inthe lung, the clinical stage of SARC seems to be the
other parts of the body although the incidence ismost important prognostic factor. The diagnosis of
more common in the upper body, particularly theSarcomatoid Carcinoma cancer requires the exclusion
lungs. Although this rare form of cancer has beenof other diseases that histologically - that is,
associated with a poor prognosis, its effect onmicroscopically - may appear similar. It is therefore
survival rates and incidence of recurrence has notmost often not confirmed as being SARC until tumor
been well documented or studied to date.sampling has been carried out.
The survival rate in patients diagnosed with SARC isSARC may be mistaken for an inflammatory
dependent upon a number of factors such as anypseudo-tumor (IP) which is the most common type
metastases and the original cause or site of theof lung cancer found predominantly in younger
cancer. In a recent study, the five year survival ratepatients who have a history of cigarette smoking.
for Sarcomatoid cancer patients was 24.5%Chest x-rays can't always distinguish between SARC
compared with 46.3% for patients with other formsand IP so again, histologic investigations as well as
of NSCLC.biopsy may be required to make an accurate
Primary pulmonary Sarcomatoid Carcinoma can onlydiagnosis.
be differentiated from other types of carcinoma byThe definitive diagnosis of Sarcomatoid Carcinoma
close examination involving immunohistochemistrywith a primary or metastatic lung sarcoma - especially
(microscopic and biologic examinations) and molecularspindle cell carcinoma - can again be difficult and
analysis. Once a tumor is identified as being SARC, itin-depth studies may be required to establish if the
is then further defined by the presence of spindle cellSARC is primary or secondary to other pulmonary
lesions in the lung. SARC may also be described as acancers. The treatment options for Sarcomatoid
Carcinosarcoma, a Pseudosarcomatoid Carcinoma orCarcinoma will vary depending upon many factors to
spindle cell Carcinoma. These are all terms whichdo with the patients overall condition.
define the lesions as seen on examination.